|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 中国药品定价和补偿政策及其效果显示文摘背景:近年来,中国药物政策存在着药品费用快速增长,以及质量、定价和提供能力等方面的问题,其解决的关键在于理清其中的定价和补偿问题。方法:本文较为系统收集了药物领域的学术文献和灰色文献,以及中国政府的官方统计数据,并结合中国国务院发展研究中心举办的研讨会信息,概述了中国的药品定价和补偿情况。结果:通过一个融合了供应方、代理方和需求方多方政策的框架,分析了定价与补偿政策。在目前药品政策的相互影响下,出现了药品价格高、质量低、不合理开药等问题。分立的监管环境也不利于药品政策的改革。结论:提高药品质量标准、市场集中度、政府补贴,以质量为导向的招标、扩大零差率政策的实施范围、建立补偿与合理开药的联动机制以及促进卫生技术评估与比较效能研究来改善定价和补偿政策。另外,整合广泛的监管分立体制、改善透明度和打击腐败等问题将有助于确保制定出具有一致性的、循证的政策。 | Jia Hu Elias Mossialos | 2017 | 中国卫生政策研究2017，10，2： | 5 |
| 2 | Analysis of the Pseudomonas aeruginosa oprD gene from clinicat and environ- mental isolates显示文摘 | Pirnay JP de Vos D Mossialos D | 2002 | Environ Microbiol2002，4，12： | 1 |
| 3 | Regulating pharmace- utical markets: improving efficiency and controlling costs in the UK显示文摘 | Walley T Mrazek M Mossialos E | 2005 | International Journal of Health Planning and Management2005，20，4： | 1 |
| 4 | Analysing the Greek Health System: A Tale of Fragmentation and Inertia显示文摘 | MOSSIALOS E ALLIN S DAVAKI K | 2005 | Health Econ2005，14，1： | 1 |
| 5 | Physician revalidation in Europe显示文摘 | Merkur S Mossialos E Long M | 2008 | Clin M ed2008，8，4： | 1 |
| 6 | Detection of a phylogenetically distinct IMP type metallo-beta lactamase,IMP 35,in a CC235 Pseudomonas aeruginosa from the Dutch-German border region (Euregio)显示文摘 | Pournaras S Kock R Mossialos D | | 0，，06： | 1 |
| 7 | Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates 显示文摘 | Pimay JP D De Ves D Mossialos | 2002 | Environ Microbiol2002，4，12： | 1 |
| 8 | Increasing demand while decreasing costs of generic medicines 显示文摘 | MRAZEK MF MOSSIALOS E | 2000 | Lancet2000，356，9244： | 1 |
| 9 | Health technology assessment and its influence on health care priority setting显示文摘 | OLIVER A MOSSIALOS E ROBINSON R | 2004 | Int J Technol Assess Health Care2004，20，1： | 1 |
| 10 | Are perceptions of ‘risks’ and ‘benefits’ of genetically modified food (in)dependent?显示文摘 | Joan Costa-Font Elias Mossialos | 2005 | Food Quality and Preference2005，，2： | 1 |
| 11 | The wanless report and decision-making in public health显示文摘 | Allin S Mossialos E McKee M | 2005 | Journal of Public Health2005，27，2： | 1 |
| 12 | Incentives for new antibiotics: the options market for antibiotics (OMA) model 显示文摘 | BROGAN DM MOSSIALOS E | 2013 | Global Health2013，9，11： | 1 |
| 13 | Analysis of the Pseudomonas aeruginosa OprD gene from clinical and environmental isolates 显示文摘 | Pimay J P De V D Mossialos D | 2002 | Environ Microbiol2002，4，12： | 1 |
| 14 | Bioactive compounds synthesized by non-ribosomal peptide synthetases and type-I polyketide synthases discovered through genome-mining and metagenomics显示文摘 | Katerina Nikolouli Dimitris Mossialos | 2012 | Biotechnology Letters2012，，8： | 1 |
| 15 | Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates显示文摘 | Pirnay JP De Vos D Mossialos D | 2002 | Environ Microbiol2002，4，12： | 1 |
| 16 | Bioactive compounds synthesized by non-ribosomal peptide synthetases and type-I polyketide synthases discovered through genome-mining and metagenomics 显示文摘 | Nikolouli K Mossialos D | 2012 | Biotechnology Letters2012，34，8： | 1 |
| 17 | The changing regional pattern of ischaemic heart disease mortality in southern Europe: still healthy but uneven progress显示文摘 | Hirte L Nolte E Mossialos E | 2008 | Journal of Epidemiology and Community Health2008，62，： | 1 |
| 18 | Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates显示文摘 | Pimay J P Vos D D Mossialos D | 2002 | Environm Microbiol2002，4，12： | 1 |
| 19 | An overview of cost sharing for health services in the European Union 显示文摘 | Thomson S Mossialos E | 2004 | Euro Observer2004，，6： | 1 |
| 20 | Finland:Health system review显示文摘 | Vuorenkoski L Mladovsky P Mossialos E | 2008 | Health Systems in Transition2008，10，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员